跳至主要内容
临床试验/CTRI/2024/05/067503
CTRI/2024/05/067503尚未招募2 期

Randomized controlled clinical study to evaluate efficacy of Vatsakadi Guggul Yog with Navak Guggul and Atorvastatin in the management of Medovriddhi with special reference to Hyperlipidemia. - NI

one0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
one

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Symptoms of Medovriddhi Shwasadhikya, Nidradhikya, Shrama, Asamarthata, Balhinata, Gaurav, Atikshudha, Atitrushna, Atisweda, Daurgandhya
  • Framingham point score with 10 year risk of CHD is less than 20 percent
  • LDL more than 130mg per dl

排除标准

  • Framingham point score with 10 year risk is more than 20 percent
  • LDL cholesterol level is less than 130mg/dl
  • Pregnant women and lactating mothers
  • Patients having history of Renal disease Liver disease cardiac disease
  • Patient having Autoimmune disease HIV or Carcinoma

研究者

发起方
one

相似试验